← All stocks

IMMUNIC, INC.

IMUX Net buying
CIK 0001280776 #3859 in the set updated 22 Sep 2026
Bought (120 mo)
$18.50M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.50M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$4.50M
16 of 16 sales
Net
+$14.00M
+$14.00M against sales at will

By person

18 insiders · 68 transactions
1.0×

Dr. Daniel Vitt holds only 1.0 times base salary in stock. $654.20K of shares against $625.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. Daniel Vitt last reported holding, valued at $0.83, the price Common Stock was last bought or sold at on the open market here, on 13 Jun 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Satter Muneer A
Director
$17.20M (17)
$4.15M (3)
+$13.05M
0
$0.00
−100.0%
Neermann Joerg
Director
$204.36K (5)
+$204.36K
200,000
$166.94K
Rudick Richard Alan
Director
$200.39K (2)
+$200.39K
230,375
$192.29K
Muehler Andreas
Chief Medical Officer
$173.34K (2)
+$173.34K
297,986
$248.73K
+4.7%
Hasnain Faheem
Director
$247.87K (1)
$77.68K (2)
+$170.19K
8,000
$6.68K
−93.7%
Whaley Glenn
Chief Financial Officer
$124.41K (8)
+$124.41K
95,510
$79.72K
+1,633%
Nash Duane
Executive Chairman
$139.98K (5)
$30.62K (1)
+$109.35K
36,032
$30.08K
Groeppel Manfred
Chief Operating Officer
$82.36K (2)
−$82.36K
278,830
$232.74K
−2.0%
BIENAIME JEAN JACQUES
Director
$88.04K (2)
$17.40K (2)
+$70.64K
18,500
$15.44K
−52.7%
Winters Terence E.
Co-Chairman and CEO
$30.98K (1)
+$30.98K
314,930
$262.87K
+3.3%
Halperin Errol R.
Director
$28.84K (2)
−$28.84K
0
$0.00
−100.0%
Vitt Daniel
Director
$65.78K (5)
$92.51K (2)
−$26.73K
783,754
$654.20K
+4.9%
Godshall Douglas Evan
Director
$24.19K (1)
−$24.19K
0
$0.00
−100.0%
Tardio Jason
President and COO
$9.88K (1)
+$9.88K
12,512
$10.44K
DUNN JOHN MICHAEL
General Counsel and Secretary
$7.72K (2)
+$7.72K
11,885
$9.92K
+26.6%
Ashley Robert A.
Chief Scientific Officer, EVP
$6.36K (1)
+$6.36K
2,000
$1.67K
Cohen Cheryl
Director
$1.93K (1)
−$1.93K
0
$0.00
−100.0%
BVF PARTNERS L P/IL entity
Director
42,762
$35.69K
0.0%

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 13,644,467 to 136,214,825 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Nash Duane
13 Jun 2025
Executive Chairman
Buy
20,000
$0.83
$16.69K
Neermann Joerg
5 Jun 2025
Director
Buy
30,000
$0.76
$22.80K
Tardio Jason
5 Jun 2025
President and COO
Buy
12,512
$0.79
$9.88K
Neermann Joerg
4 Jun 2025
Director
Buy
70,000
$0.77
$53.90K
Vitt Daniel
4 Jun 2025
CEO and Director
Buy
15,000
$0.77
$11.55K
Rudick Richard Alan
3 Jun 2025
Director
Buy
143,075
$0.70
$100.02K
Whaley Glenn
3 Jun 2025
Chief Financial Officer
Buy
45,000
$0.71
$32.08K
Rudick Richard Alan
12 Nov 2024
Director
Buy
87,300
$1.15
$100.37K
Vitt Daniel
26 Feb 2024
President and CEO
Buy indirect
14,000
$1.31
$18.33K
Whaley Glenn
15 May 2023
Chief Financial Officer
Buy
5,000
$1.75
$8.75K
Neermann Joerg
14 Dec 2022
Director
Buy
47,000
$1.26
$59.03K
Neermann Joerg
13 Dec 2022
Director
Buy
35,000
$1.25
$43.61K
Neermann Joerg
23 Nov 2022
Director
Buy
18,000
$1.39
$25.02K
Vitt Daniel
22 Nov 2022
President and CEO
Buy indirect
8,000
$1.35
$10.80K
Whaley Glenn
7 Nov 2022
Chief Financial Officer
Buy
5,000
$1.50
$7.48K
Whaley Glenn
3 Jun 2022
Chief Financial Officer
Buy
3,500
$3.05
$10.66K
Vitt Daniel
3 Jun 2022
President and CEO
Buy indirect
5,000
$3.10
$15.50K
Nash Duane
12 May 2022
Executive Chairman
Buy
10,000
$5.03
$50.30K
Whaley Glenn
12 May 2022
Chief Financial Officer
Buy
3,000
$5.08
$15.24K
Muehler Andreas
12 May 2022
Chief Medical Officer
Buy
3,500
$5.10
$17.85K
Nash Duane
10 Aug 2021
Executive Chairman
Buy
1,000
$9.80
$9.80K
Vitt Daniel
10 Aug 2021
President and CEO
Buy indirect
1,000
$9.60
$9.60K
Whaley Glenn
10 Aug 2021
PFO and PAO
Buy
1,500
$9.85
$14.78K
Nash Duane
12 May 2021
Executive Chairman
Buy
4,000
$12.75
$51.00K
Whaley Glenn
2 Mar 2021
PFO and PAO
Buy
1,000
$16.48
$16.48K
Muehler Andreas
2 Mar 2021
Chief Medical Officer
Buy
10,006
$15.54
$155.49K
Whaley Glenn
10 Aug 2020
PFO and PAO
Buy
1,000
$18.96
$18.96K
Satter Muneer A
13 Dec 2017
Director
Buy indirect
50,000
$5.57
$278.57K
Satter Muneer A
12 Dec 2017
Director
Buy indirect
50,000
$5.40
$269.77K
Satter Muneer A
11 Dec 2017
Director
Buy indirect
50,000
$4.96
$248.23K
Satter Muneer A
8 Dec 2017
Director
Buy indirect
50,000
$4.92
$246.19K
Satter Muneer A
7 Dec 2017
Director
Buy indirect
50,000
$4.77
$238.73K
Satter Muneer A
14 Sep 2017
Director
Buy indirect
30,000
$4.25
$127.54K
Hasnain Faheem
14 Sep 2017
Director
Buy
59,200
$4.19
$247.87K
BIENAIME JEAN JACQUES
13 Sep 2017
Director
Buy
10,000
$4.00
$39.97K
Satter Muneer A
13 Sep 2017
Director
Buy indirect
50,000
$4.13
$206.47K
Satter Muneer A
12 Sep 2017
Director
Buy indirect
50,000
$3.74
$187.23K
Satter Muneer A
8 Sep 2017
Director
Buy indirect
50,000
$3.53
$176.62K
Satter Muneer A
14 Jun 2017
Director
Buy indirect
10,000
$3.10
$31.01K
Winters Terence E.
14 Jun 2017
Co-Chairman and CEO
Buy
10,000
$3.10
$30.98K
DUNN JOHN MICHAEL
14 Jun 2017
General Counsel and Secretary
Buy
2,400
$3.09
$7.42K
DUNN JOHN MICHAEL
14 Jun 2017
General Counsel and Secretary
Buy
100
$3.08
$307.50
Satter Muneer A
13 Jun 2017
Director
Buy indirect
10,000
$3.03
$30.31K
BIENAIME JEAN JACQUES
13 Jun 2017
Director
Buy
16,000
$3.00
$48.07K
Satter Muneer A
12 Jun 2017
Director
Buy indirect
10,000
$3.06
$30.62K
Satter Muneer A
9 Jun 2017
Director
Buy indirect
10,000
$3.17
$31.73K
Ashley Robert A.
9 Jun 2017
Chief Technical Officer, EVP
Buy
2,000
$3.18
$6.36K
Nash Duane
8 Jun 2017
President
Buy
3,900
$3.12
$12.18K
Satter Muneer A
8 Jun 2017
Director
Buy indirect
10,000
$3.10
$30.96K
Satter Muneer A
7 Jun 2017
Director
Buy indirect
10,000
$3.21
$32.07K
Satter Muneer A
6 Jun 2017
Director
Buy indirect
10,000
$3.19
$31.94K
Satter Muneer A
27 Mar 2017
Director
Buy indirect
3,750,000
$4.00
$15.00M

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 61,087
Sales filed before the plan box existed 16
History held since 27 Mar 2017